Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
 Disease Category: Diabetes Mellitus, Type 2
Location: United States, NY

Trial Information

Sitagliptin Dose Determination Study in Type 1 Diabetes

The main purpose of this study is to see if the study medication Januvia (a pill) improves after meal blood sugars along with insulin in kids and adults with newly diagnosed Type 1 Diabetes and established diabetes. We will also compare how quickly food leaves the stomach during different parts of the study. Study includes 5 outpatient visits over a 6 to 9 month period for out of which 4 are about 11 hour long visits. You will be compensated to a total of 750 dollars for the entire study.

Patient Inclusion Criteria:

  • Between 13 and 30 years of age
  • Diagnosed with Type 1 Diabetes within the past 3 months or have had Diabetes for more than a year

Patient Exclusion Criteria:

  • Younger than 13 years of age
  • Older than 30 years of age
  • Have not been diagnosed with Type 1 Diabetes

Jeniece Trast, RN, CDE, MA, Clinical Research Nurse Manager
Einstein-Montefiore Institute for Clinical & Translational Research
Montefiore Medical Center
Division of Pediatric Endocrinology
111 East 210th Street
Bronx, NY 10467
Phone: 718-741-2542
Email: jtrast@montefiore.org

View Map

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.